Paper38468331
The relative and combined ability of stress hyperglycemia ratio and N-terminal pro-B-type natriuretic peptide to predict all-cause mortality in diabetic patients with multivessel coronary artery disease.
Wang L and 10 others. Cardiovasc Diabetol, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. The relative and combined ability of stress hyperglycemia ratio and N-terminal pro-B-type natriuretic peptide to predict all-cause mortality in diabetic patients with multivessel coronary artery disease. Papers, record 38468331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38468331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
The relative and combined ability of stress hyperglycemia ratio and N-terminal pro-B-type natriuretic peptide to predict all-cause mortality in diabetic patients with multivessel coronary artery disease.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Artery Disease | Major topic |
| Diabetes Mellitus | Major topic |
| Hyperglycemia | Major topic |
| Humans | |
| Natriuretic Peptide, Brain | |
| Prognosis | |
| Biomarkers | |
| Peptide Fragments |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| TJWJ2022MS035 | Tianjin Health Commission | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32816995 | Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications. | Diabetes Care | 2020 | https://conductscience.org/library/papers/32816995 | PubMed |
| 2 | 35351149 | Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study. | Cardiovasc Diabetol | 2022 | https://conductscience.org/library/papers/35351149 | PubMed |
| 3 | 29654205 | Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia. | J Am Heart Assoc | 2018 | https://conductscience.org/library/papers/29654205 | PubMed |
| 4 | 29382659 | Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Acute Myocardial Infarction: A Prospective Study. | Diabetes Care | 2018 | https://conductscience.org/library/papers/29382659 | PubMed |
| 5 | 15542281 | Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. | J Am Coll Cardiol | 2004 | https://conductscience.org/library/papers/15542281 | PubMed |
| 6 | 38042441 | Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: A systematic review with Bayesian and frequentist meta-analysis. | Trends Cardiovasc Med | 2024 | https://conductscience.org/library/papers/38042441 | PubMed |
| 7 | 32964800 | NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus. | J Am Heart Assoc | 2020 | https://conductscience.org/library/papers/32964800 | PubMed |
| 8 | 37865764 | Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from american MIMIC-IV and the chinese CIN-II study. | Cardiovasc Diabetol | 2023 | https://conductscience.org/library/papers/37865764 | PubMed |
| 9 | 36722252 | Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta-analysis of randomized placebo-controlled outcome trials. | Diabetes Obes Metab | 2023 | https://conductscience.org/library/papers/36722252 | PubMed |
| 10 | 29848776 | Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial. | Diabetes Care | 2018 | https://conductscience.org/library/papers/29848776 | PubMed |
| 11 | 35772392 | Stress hyperglycemia ratio and long-term mortality after acute myocardial infarction in patients with and without diabetes: A prospective, nationwide, and multicentre registry. | Diabetes Metab Res Rev | 2022 | https://conductscience.org/library/papers/35772392 | PubMed |
| 12 | 36755256 | Association between the stress hyperglycemia ratio and severity of coronary artery disease under different glucose metabolic states. | Cardiovasc Diabetol | 2023 | https://conductscience.org/library/papers/36755256 | PubMed |
| 13 | 36623641 | Fasting stress hyperglycemia ratio and in-hospital mortality after acute myocardial infarction in patients with different glucose metabolism status: Results from China acute myocardial infarction registry. | Diabetes Res Clin Pract | 2023 | https://conductscience.org/library/papers/36623641 | PubMed |
| 14 | 33888145 | Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study. | Cardiovasc Diabetol | 2021 | https://conductscience.org/library/papers/33888145 | PubMed |
| 15 | 31497854 | 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. | Eur Heart J | 2020 | https://conductscience.org/library/papers/31497854 | PubMed |
| 16 | 38057783 | Impact of stress hyperglycemia ratio, derived from glycated albumin or hemoglobin A1c, on mortality among ST-segment elevation myocardial infarction patients. | Cardiovasc Diabetol | 2023 | https://conductscience.org/library/papers/38057783 | PubMed |
| 17 | 27206819 | 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. | Eur Heart J | 2016 | https://conductscience.org/library/papers/27206819 | PubMed |
| 18 | 37403082 | The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry. | Cardiovasc Diabetol | 2023 | https://conductscience.org/library/papers/37403082 | PubMed |
| 19 | 10711923 | Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. | Lancet | 2000 | https://conductscience.org/library/papers/10711923 | PubMed |
| 20 | 37132473 | Stress hyperglycemia ratio and long-term prognosis in patients with acute coronary syndrome: A multicenter, nationwide study. | J Diabetes | 2023 | https://conductscience.org/library/papers/37132473 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41688977 | Stress hyperglycemia ratio in coronary artery disease: a systematic review and meta-analysis of severity and prognosis. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/41688977 | PubMed |
| 41404508 | Hyperglycemia, diabetes, and coronary microvascular dysfunction in INOCA. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41404508 | PubMed |
| 40355885 | Prognostic significance of stress hyperglycemia ratio in patients with type 2 diabetes mellitus and acute coronary syndromes. | Thromb J | 2025 | https://conductscience.org/library/papers/40355885 | PubMed |
| 40275310 | Association of stress hyperglycemia ratio with short-term and long-term prognosis in patients undergoing coronary artery bypass grafting across different glucose metabolism states: a large-scale cohort study. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/40275310 | PubMed |
| 40128747 | The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/40128747 | PubMed |
| 39497069 | Predictive factors for multivessel disease in patients with acute coronary syndrome: analysis from the CCC-ACS project in China. | BMC Cardiovasc Disord | 2024 | https://conductscience.org/library/papers/39497069 | PubMed |
| 39342410 | The relative and combined ability of triglyceride-glucose index and stress hyperglycemia ratio to predict major adverse cardio-cerebral events in patients with multivessel coronary artery disease. | Diabetol Metab Syndr | 2024 | https://conductscience.org/library/papers/39342410 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38468331
GET https://conductscience.org/api/papers/v1/38468331/references?page=2